Ria Health is a national telehealth provider delivering evidence-based treatment for alcohol use disorder (AUD) that combines medication‑assisted treatment, behavioral therapy, and coaching through a physician‑led clinical team. The program is designed to meet patients seeking either harm reduction or abstinence and partners with facility‑based AUD providers and digital health companies. Ria operates via telehealth across all 50 states and has contracts with 15 payors, using value‑based payor arrangements that align incentives around quality metrics and phased service utilization. The company highlights industry‑leading outcomes and significant reductions in medical spend for payor partners. With the new capital, Ria plans to scale its clinical model and payor coverage, accelerate sales and marketing investments, and strengthen its position as a value‑add partner in the AUD care continuum. Ria Health operates an online telehealth platform that pairs a smartphone app with a Bluetooth-equipped breathalyzer to monitor blood alcohol levels and share results with counselors. Their program includes a HIPAA-compliant video portal and access to a health team—psychiatrists, addiction medicine physicians, and certified addiction counselors—plus anonymized and family-involved support groups. The company emphasizes technology to expand access and engagement while preserving human-to-human clinical interactions. Ria Health began its mission in 2017 and is positioning its platform for broader validation through clinical research. It recently received a $2 million grant from the National Institutes of Health to support clinical trials being conducted with the Stanford Prevention Research Center. The grant will fund development of additional technology features aimed at improving patient engagement and treatment outcomes. Ria Health offers an evidence-based telehealth treatment program for alcohol use disorder that combines medical science, technology, and human compassion. Led by CEO Tom Nix, the program combines one-on-one coaching, medical support, digitally connected breathalyzers, and physician-prescribed medications. Expert providers empower patients to set personalized goals that may focus on clinically-measured reduction of alcohol misuse rather than abstinence. The company has commercial partnerships with regional and national health plans, including Anthem Blue Cross Blue Shield, UnitedHealth Group Optum, Beacon Health Options, Highmark Health, and Magellan Health. Ria intends to use the funding to expand care delivery to meet demand from health plans, multi-state employers, Taft-Hartley plans, and healthcare providers. No operating metrics or revenue figures were disclosed in the announcement.

Total raised

$20M

Funding rounds

3

Latest round

Grant

Latest activity

Nov 2022